Influence of Nanocarrier Type on the Drug Delivery Aspects of Docetaxel: Empirical Evidences
No Thumbnail Available
Date
2022-08
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
Abstract
Docetaxel (DTX) is one of the anti-neoplastic drugs widely employed in breast cancer management. Along with advantages, several challenges are associated with administering the BCS class IV drugs like DTX. Looking into the promises of various nanotechnology-based drug delivery systems, it was envisioned to explore the influence of carrier type on the drug delivery outcome for this anticancer agent.
Description
Keywords
Pharmacy, Drug Delivery, Nanocarriers, Docetaxel (DTX), Anticancer therapy